ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Ann Med Res. 2009; 16(3): 193-195


Treatment of the Tinnitus Caused by Palatal Myoclonus with Botulinum Toxin

 

Mustafa Akarçay*, Ahmet Kızılay*, Orhan Özturan**

.



Abstract
Download PDF Post


 

Introduction: Palatal myoclonus (PM) is a rare cause of objective tinnitus, secondary to rhythmic voluntary or involuntary movements of the soft palate.

Cases: We report two cases; nineteen-year-old girl and 18-year-old boy who presented our clinic with bilateral tinnitus and diagnosed as PM. Clinical diagnosis was made on the confirmation of soft palate movements synchronus with an audible clicking noise. Neurologic examination, cranial MR and MR angiography were normal in both patients. Since the systemic drug therapy was unsuccessful, 15 U botulinum neurotoxin A (botox-A) (BOTOX®, Allergan, Inc., Irvine, CA, USA) has injected into both sides of the soft palate in patients. Tinnitus has disappeared immediately after the injections. There were not any complaint after twenty months follow-up.

Conclusion: In the light of literature, our findings show that botox-A injection is an effective treatment in PM.

Key Words: Myoclonus, Botulinum Neurotoxin A, Objective Tinnitus





Bibliomed Article Statistics

21
17
40
30
33
50
36
27
51
46
38
18
R
E
A
D
S

38

19

23

26

25

86

20

12

30

21

26

12
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.